Trade JnJ ^JNJ

Johnson & Johnson (NYSE:JNJ) Stock Price Down 3.6% - Time to Sell?

Decongestant class action sputters back to life in Second Circuit

Hamilton Wealth LLC Buys 2,542 Shares of Johnson & Johnson $JNJ - Zolmax

Janus Henderson Group PLC Has $1.92 Billion Position in Johnson & Johnson $JNJ - Zolmax

Best Healthcare Stocks To Keep An Eye On - July 29th - Stock Observer

South Dakota Investment Council Lowers Position in Johnson & Johnson $JNJ - Markets Daily

Johnson & Johnson $JNJ is Tri Locum Partners LP's Largest Position

Johnson & Johnson $JNJ Shares Sold by Stempoint Capital LP

Tri Locum Partners LP Sells 188,640 Shares of Johnson & Johnson $JNJ - Stock Observer

Bank of America Corp DE Trims Stock Holdings in Johnson & Johnson $JNJ

J&J Strikes $3.51 Bln Deal With Sail To Develop In-Vivo CAR-T Therapies For Immune Diseases

Johnson & Johnson $JNJ Shares Acquired by Hamilton Wealth LLC - Daily Political

Johnson & Johnson seeks to end decade-long talc litigation with $5.5 billion settlement - The Economic Times

Johnson & Johnson (JNJ) Seeks $5.5 Billion Talc Lawsuit Settlement

Johnson & Johnson Comes to Strategic Agreement with Sail Biomedicines | Morningstar

Trump questions the validity of Fauci pardon due alleged use of autopen by Biden | Watch News Videos Online

Trump vows to hit Iran 'very hard' after Iranian attack on US base in Jordan | Watch News Videos Online

Sail Biomedicines Announces Strategic Collaboration to Develop New Class of Medicines for In Vivo CAR-T

Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation | INN

Johnson & Johnson agrees to pay billions in cancer lawsuit settlement - AOL

Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset | INN

Explainer-Can J&J finally put the talc litigation behind it? - AOL

Agentic AI startup Freehand closes $75 million funding

Johnson & Johnson baby powder causing cancer? What is behind the $5.5 billion settlement

Johnson & Johnson vs. Eli Lilly: Reliable Stability vs. Rapid Revenue Growth

Smith Group Asset Management LLC Acquires 11,139 Shares of Johnson & Johnson $JNJ - Zolmax

Best Medical Stocks Worth Watching - July 28th

Johnson & Johnson baby powder controversy: Does your baby really need talcum powder? - India Today

EverSource Wealth Advisors LLC Boosts Holdings in Johnson & Johnson $JNJ

Why Johnson & Johnson agreed to pay $5.5 billion despite denying cancer claims

Arete Wealth Advisors LLC Acquires 11,789 Shares of Johnson & Johnson $JNJ

Amundi Has $3.28 Billion Stock Holdings in Johnson & Johnson $JNJ

J&J's $5.5 billion talc settlement: Look at biggest corporate payouts in history

EverSource Wealth Advisors LLC Raises Holdings in Johnson & Johnson $JNJ - Stock Observer

Smith Group Asset Management LLC Has $36.70 Million Holdings in Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson (NYSE:JNJ) EVP Vanessa Broadhurst Sells 23,054 Shares of Stock - Daily Political

J&J seals deal to end a decade of cancer litigation

Mint Quick Edit | Johnson & Johnson's $5.5 billion offer to settle cancer-risk suits: is money enough? | Mint

How a 44-Year-Old Could Build a $9,000 Monthly Paycheck by 60 Without Maxing a 401(k)

De-escalation trials in multiple myeloma: past, present and future

What Johnson & Johnson Stock Told You Before It Surged

Johnson & Johnson (JNJ) Stock: Surges as J&J Offers $5.5 Billion Talc Settlement to End Cancer Lawsuits

Johnson & Johnson (JNJ) Stock May Be 31% Undervalued As Myeloma Trial Results Impress

Johnson & Johnson To Settle Baby Powder Lawsuit Over A Decade Later - AOL

Johnson & Johnson agrees to $5.5B settlement over talc cancer claims | Fox Business

Johnson & Johnson (NYSE:JNJ) EVP Vanessa Broadhurst Sells 23,054 Shares - Markets Daily

Johnson & Johnson proposes $5.5B settlement to resolve remaining talc litigation

Johnson & Johnson offers up to $5.5 billion to settle baby powder cancer lawsuits

J&J reaches sweeping talc deal that could end decade of litigation

Johnson & Johnson Offers $5.5bn Talc Settlement: Who Could Qua...

Johnson & Johnson agrees to USD 5.5 billion settlement in talc litigation case

Johnson & Johnson settling talc baby powder lawsuits for $5.5 billion

Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight - AOL

Johnson & Johnson creates $5.5B fund to settle baby powder lawsuits

Is talcum powder safe?

Vanessa Broadhurst Sells 23,054 Shares of Johnson & Johnson (NYSE:JNJ) Stock - Stock Observer

Johnson & Johnson (NYSE:JNJ) Sets New 1-Year High - Here's What Happened - Stock Observer

Johnson & Johnson's $5.5 billion talc lawsuit settlement: Here's what the deal covers

Johnson & Johnson $JNJ Shares Acquired by Evelyn Partners Investment Management Services Ltd

Johnson & Johnson $JNJ Shares Sold by Evercore Wealth Management LLC

Johnson & Johnson to pay nearly ₹52,700 crore after lawsuits linked baby powder to ovarian cancer | Company Business News

Johnson & Johnson offers £4.1bn to settle talcum powder cancer claims

Healthcare Stocks To Keep An Eye On - July 28th - Daily Political

Johnson & Johnson hasagreed to pay $5.5 billion over talc claims. Here's how the legal battle finally ended

Johnson & Johnson offers $5.5B to settle talc lawsuits | The Manila Times

Rokos Capital Management LLP Has $5.94 Million Holdings in Johnson & Johnson $JNJ - Stock Observer

Johnson & Johnson Offers $5.5 Billion to End Talc Lawsuits - Yahoo News Canada

Johnson & Johnson reaches proposed $5.5B talcum powder settlement

Johnson & Johnson seeks to end baby powder cancer lawsuits with $5.5bn deal

Johnson & Johnson proposes RM223b settlement for talc cancer lawsuits

The Manufacturers Life Insurance Company Sells 198,816 Shares of Johnson & Johnson $JNJ - Daily Political

Johnson And Johnson Talc Settlement Puts Colgate And Kimberly Clark Stock In Focus

'Finality to a saga': Johnson & Johnson commits $5.5 billion to resolve ovarian cancer claims

Johnson & Johnson announces $7 billion settlement of talc lawsuits | The Straits Times

Johnson & Johnson offers up to $5.5bn to settle baby powder lawsuits

J&J offers $5.5bn settlement in lawsuits claiming talc link to cancer | Courts News | Al Jazeera

Johnson & Johnson announces US$5.5 billion settlement of talc lawsuits - The Business Times

Johnson & Johnson reaches $5b talc lawsuits settlement

After a Decade of Fighting Johnson & Johnson, Families Win a Historic $5.5 Billion Talc Settlement | Valuespectrum.com

Johnson and Johnson Agrees to $5.5 Billion Talc Cancer Settlement

Johnson & Johnson Agrees to Pay Up to $5.5 Billion to Settle Talc Lawsuits - Update | Morningstar

Johnson & Johnson announces $5.5 billion settlement of talc lawsuits

Johnson & Johnson Agrees to Pay Up to $5.5 Billion to Settle Talc Lawsuits | Morningstar

Johnson & Johnson (NYSE:JNJ) Trading 1.1% Higher - Should You Buy? - Markets Daily

Johnson & Johnson (JNJ) Raised Its Outlook. Is It the Better Healthcare Stock to Own After Earnings?

Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer

Johnson & Johnson (NYSE:JNJ) Shares Up 1.1% - Here's What Happened - Stock Observer

Forget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a Paycheck

 Week Ahead: Inflation Data from U.S., Canada, and U.K. Take Centre Stage

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: BoC and ECB Interest Rate Decisions in Focus This Week

Week ahead: ECB set to cut as Wall Street earnings season gathers pace

Week ahead: US earnings season kicks off, ECB hold expected

Europe Tries to Ride on US Coat-tails

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk